Home
Conditions
Neoplasms, Connective Tissue

Clinical trial condition

Neoplasms, Connective Tissue

Explore clinical trials studying Neoplasms, Connective Tissue. Study availability and eligibility vary by location and protocol.

1,268 public trials 269 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Connective Tissue trial results

Completed

Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803

NCT02890758

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma of Rectum, +65 more
Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Cabozantinib With Topotecan-Cyclophosphamide

NCT04661852

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +9 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Drug Sensitivity and Mutation Profiling

NCT04956198

Conditions: Childhood Sarcoma of Soft Tissue, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ewing Sarcoma, +28 more
Locations: Nicklaus Children's Hospital Miami, Florida, United States

View Trial Details

Completed

Nutrition in Gastrointestinal Tumors

NCT04476082

Conditions: Bile Duct Cancer, Bile Duct Diseases, Bile Duct Neoplasms, +42 more
Locations: University Medicine Greifswald Greifswald, Germany

View Trial Details

Completed

A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs

NCT02712112

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +7 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Completed

PDR001 Plus Imatinib for Metastatic or Unresectable GIST

NCT03609424

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Completed

A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma

NCT02511132

Conditions: Ewing's Sarcoma, Neoplasms, Neoplasms by Histologic Type, +6 more
Locations: Arkansas Children's Hospital Little Rock, Arkansas, United States

Nicklaus Children's Hospital (Miami Children's Health System) Miami, Florida, United States

Memorial Sloan Kettering Cancer Center New York, United States

Cleveland Clinic Children's Cleveland, Ohio, United States

View Trial Details

Completed

The HEADWIND Study - Part 4

NCT05308095

Conditions: Abnormalities, Multiple, Autoimmune Diseases, Cardiovascular Diseases, +22 more
Locations: University Department of Endocrinology, Diabetology, Clinical Nutrition and Metabolism Bern, Switzerland

View Trial Details

Completed

PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma

NCT00346125

Conditions: Fibrosarcoma, Histiocytoma, Histiocytoma, Malignant Fibrous, +20 more
Locations: Sinai Hospital of Baltimore Baltimore, Maryland, United States

Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)

NCT04978740

Conditions: Immune System Diseases, Mast Cell Activation Disease, Mast Cell Activation Disorders, +14 more
Locations: Masson Regnault Poitiers, New Aquitaine, France

View Trial Details

Neoplasms, Connective Tissue

Neoplasms, Connective Tissue trial results

Related conditions